arXiv subjects

Kailong Fan

Publications and source records attributed to Kailong Fan.

3 recordsLinked to original sources

arXiv2026

Hallucination-Aware Diffusion Sampling for Inverse Problems via Robust Prior Updates

Diffusion-based inverse problem solvers can produce realistic reconstructions, but realism alone does not ensure that the recovered details are supported by the measurement. We study this failure as measurement-conditioned hallucination: visually meaningful content that is either implausible or inconsistent with the measured instance. Our analysis separates Bayes-rule-based diffusion inverse solvers into a prior update and a measurement-conditioning step, showing that hallucinated content can enter through the prior-side proposal before the measurement correction is applied. Motivated by this view, we propose Robust Prior Update (RPU), a solver-level module that probes the local stability of the diffusion prior update, re-anchors the resulting displacement at the current iterate, and leaves the measurement update unchanged. We instantiate RPU in DPS and evaluate it on FFHQ and ImageNet inverse problems using automatic metrics and human faithfulness studies. On FFHQ, RPU improves PSNR and LPIPS over DPS across box inpainting, Gaussian deblurring, and motion deblurring. In human judgments, RPU receives 91.9% of blind non-tie majority preferences and 91.1% of ground-truth-assisted non-tie preferences on FFHQ box inpainting, while the ImageNet Gaussian reader study is tie-heavy but favors RPU among non-tie cases. These results support a targeted claim: robustifying the prior update can improve instance faithfulness in diffusion inverse solvers, especially when the prior shapes weakly constrained content.

cs.CV↗

arXiv2026

MAPLE: Elevating Medical Reasoning from Statistical Consensus to Process-Led Alignment

Recent advances in medical large language models have explored Test-Time Reinforcement Learning (TTRL) to enhance reasoning. However, standard TTRL often relies on majority voting (MV) as a heuristic supervision signal, which can be unreliable in complex medical scenarios where the most frequent reasoning path is not necessarily the clinically correct one. In this work, we propose a novel and unified training paradigm that integrates medical process reward models with TTRL to bridge the gap between test-time scaling (TTS) and parametric model optimization. Specifically, we advance the TTRL framework by replacing the conventional MV with a fine-grained, expert-aligned supervision paradigm using Med-RPM. This integration ensures that reinforcement learning is guided by medical correctness rather than mere consensus, effectively distilling search-based intelligence into the model's parametric memory. Extensive evaluations on four different benchmarks have demonstrated that our developed method consistently and significantly outperforms current TTRL and standalone PRM selection. Our findings establish that transitioning from stochastic heuristics to structured, step-wise rewards is essential for developing reliable and scalable medical AI systems

cs.LG↗

arXiv2026

CoMMa: Contribution-Aware Medical Multi-Agents for Decentralized Oncology Decision Support

Recent multi-agent frameworks have shown promise for oncology decision support, yet most assume centralized data access and rely on prompt-based assignment, limiting their applicability in privacy-sensitive clinical settings. We propose Contribution-Aware Medical Multi-Agents (CoMMa), a decentralized LLM-agent framework where specialists operate on partitioned clinical data streams. Unlike prior approaches that share inputs across agents, CoMMa enforces data decentralization to include stronger role specialization and further enhances this via agent-specific finetuning. To enable reliable and interpretable coordination, we introduce a contribution-aware aggregation mechanism that replaces stochastic, narrative-based reasoning with deterministic embedding projections to approximate each agent's marginal utility. This yields explicit credit assignment over agents, providing a stable and interpretable decision pathway aligned with clinical requirements. We evaluate CoMMa on multiple oncology benchmarks, including real-world multidisciplinary tumor board datasets from large academic hospitals in North America and East Asia, as well as public datasets, demonstrating strong performance and generalization across heterogeneous clinical settings.

cs.AI↗